Source: WA Business News Australia

NRW: MACA moves to diffuse NRW pressure

MACA has told investors that a merger proposal made public by contracting rival NRW yesterday is not superior to an existing all-cash takeover currently on the table from Queensland-based Thiess.

Read full article »
NRW's Competitors | NRW's News | NRW's Financials

January 28, 2023

Pharmabiz

US FDA approves Abbott's Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy

Abbott announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal c... See more »

January 27, 2023

Seeking Alpha

Eli Lilly wins FDA accelerated approval for lymphoma therapy

See more »

January 28, 2023

Pharmabiz

US FDA approves Abbott's Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy

Abbott announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal c... See more »

January 27, 2023

Seeking Alpha

Eli Lilly wins FDA accelerated approval for lymphoma therapy

See more »
Stay up-to-date with the latest news on NRW
Annual Revenue
$761.3M
Employees
3,500
Julian Pemberton's photo - CEO of NRW

CEO

Julian Pemberton

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on NRW